Redsense signs first agreement in the Middle East with a distributor in Iran

Redsense Medical has signed an agreement to distribute the company's Redsense system in Iran with local distributor Arena Darman Hegmataneh, and the first orders are expected during 2017. The agreement is an important step towards establishing the company in the Middle East. Iran invests heavily in the healthcare sector and has a dialysis market three times as big as the Swedish market.

Redsense Medical has up until now mainly focused on selling the company's leading monitoring and alarm system for blood leakage in connection with dialysis on key markets in Europe and North America. As an effect of a steadily increasing market acceptance in these regions, the system is now also beginning to attract interest on additional markets, including the Middle East.

Iran constitutes an important market in the region, with recent and ongoing substantial investments in healthcare and medical equipment. The number of patients receiving hemodialysis is steadily increasing and currently amounts to around 12 500, which is approximately three times as many as in Sweden.

“This distribution agreement for our Redsense system in Iran highlights its global market potential, and it is a promising first step towards further establishing the company in the Middle East. Since the distributor contacted us with an active interest in our system we are optimistic about receiving orders in 2017, thus contributing to improved dialysis care for patients in Iran”, says Patrik Byhmer, CEO of Redsense Medical.

Arena Darman Hegmataneh Co. Ltd. has close and long-term contact with over 500 hospitals and other healthcare institutions across Iran, and the Iranian Ministry of Health has listed Redsense Medical as a manufacturer of medical equipment. The distributor is now awaiting the final regulatory approval for the actual import of the products to Iran.

For more information, please contact
Patrik Byhmer, CEO Redsense Medical AB (publ)
Telephone: +46 (0) 35 - 10 60 30

This press release is a translation of the Swedish original that was published 2017-05-12, and it was previously posted exclusively on the Redsense Medical website. It was added to the Redsense news channel as a formatted document in September 2017 during the process of preparing the company for a list change to Nasdaq First North.

About Redsense Medical
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense system, a medical technology product used for monitoring and alarm in the case of blood leakage in connection with hemodialysis. Redsense solves one of the most serious remaining safety problems within hemodialysis – to quickly detect venous needle dislodgement and catheter leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.


Documents & Links